Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome

Volume: 43 Number: 2 June 1, 2016
  • Fesih Aktar
  • Kamuran Karaman
  • Berfin Özgökçe Özmen
  • Muhammed Akıl
  • Gökmen Taşkın
  • Hüseyin Çaksen
TR EN

Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome

Abstract

Sjögren-Larsson syndrome (SLS) is a rare neurocutaneous disease showing an autosomal recessive transmission due to a lack of fatty acid aldehyde dehydrogenase. Spastic diplegia or triplegia, mental retardation and congenital lamellar ichthyosis are the major findings of the disease. The syndrome may be accompanied by various eye and teeth features, skeletal system anomaly, speaking defects, hypertelorism and epilepsy. A 9-month male patient has been hospitalized for convulsion and flaking on body. The patient history showed that flaking skin thickening and peeling was started at the birth, and he suffered a right-side focused seizure when he was three month-old and he was treated with phenobarbital and carbamazepine upon the epilepsy diagnosis. Wide ichthyosis, hypertelorism and bilateral simian line were observed in the physical examination. Bilateral punctuate lesions in cornea, pigment epithelial atrophy in the right eye and esotropia in the left eye have been determined during the eye examination. An epiteliform anomaly has been observed in the left hemisphere by electroencephalography. In brain magnetic resonance imaging (MRI), an increase in cerebral-cerebellar brain parenchyma and T1-T2 relaxation time and in the signal in corpus callosum (delayed myelination) have been determined. With the observation of the white matter in centrum semi oval using brain MRI spectroscopy, signs of a sphingolipid peak at 1.3 ppm have been observed. An SLS diagnosis has been proposed upon clinical and laboratory observations. We want to emphasize on the fact that in epilepsy cases with ichthyosis, SLS should be considered.

Keywords

References

  1. 1. Sillén A, Alderborn A, Pigg M, et al. Detailed genetic and physical mapping in the Sjögren Larsson syndrome gene region in 17p11.2. Hereditas 1998;128:245-250.
  2. 2. Fuijkschot J, Theelen T, Seyger MM, et al. Sjögren-Larsson syndrome in clinical practice. J Inherit Metab Dis 2012;35:955-962.
  3. 3. Zribi H, A Souissi, Azzouz H, et al. Sjogren Larsson syndrome: a rare neurocutaneous disease. Rev Neurol (Paris) 2014;170:297-298.
  4. 4. Tanteles GA, Nicolaou M, Patsia N, et al. A rare cause of pruritic ichthyosis: Sjögren-Larsson syndrome in the first reported patients of Cypriot descent. Eur J Dermatol 2015;25:495-496.
  5. 5. Gomori JM, Leibovici V, Ziotogorski A, et al. Computed tomography in Sjögren-Larsson syndrome. Neuroradiology 1987;29:557-559.
  6. 6. Nakayama M, Tavora DG, Alvim TC, et al. MRI and 1HMRS findings of three patients with Sjogren-Larsson syndrome. Arq Neuropsiquiatr 2006;64:398-401.
  7. 7. Willemsen MA, Rotteveel JJ, Steijlen PM, et al. 5-Lipoxygenase inhibition: a new treatment strategy for SjogrenLarsson syndrome. Neuropediatrics 2000;31:1-3.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Fesih Aktar This is me

Kamuran Karaman This is me

Berfin Özgökçe Özmen This is me

Muhammed Akıl This is me

Gökmen Taşkın This is me

Hüseyin Çaksen This is me

Publication Date

June 1, 2016

Submission Date

June 1, 2016

Acceptance Date

-

Published in Issue

Year 2016 Volume: 43 Number: 2

APA
Aktar, F., Karaman, K., Özgökçe Özmen, B., Akıl, M., Taşkın, G., & Çaksen, H. (2016). Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal, 43(2), 356-359. https://izlik.org/JA89CX28RH
AMA
1.Aktar F, Karaman K, Özgökçe Özmen B, Akıl M, Taşkın G, Çaksen H. Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal. 2016;43(2):356-359. https://izlik.org/JA89CX28RH
Chicago
Aktar, Fesih, Kamuran Karaman, Berfin Özgökçe Özmen, Muhammed Akıl, Gökmen Taşkın, and Hüseyin Çaksen. 2016. “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”. Dicle Medical Journal 43 (2): 356-59. https://izlik.org/JA89CX28RH.
EndNote
Aktar F, Karaman K, Özgökçe Özmen B, Akıl M, Taşkın G, Çaksen H (June 1, 2016) Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal 43 2 356–359.
IEEE
[1]F. Aktar, K. Karaman, B. Özgökçe Özmen, M. Akıl, G. Taşkın, and H. Çaksen, “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”, Dicle Medical Journal, vol. 43, no. 2, pp. 356–359, June 2016, [Online]. Available: https://izlik.org/JA89CX28RH
ISNAD
Aktar, Fesih - Karaman, Kamuran - Özgökçe Özmen, Berfin - Akıl, Muhammed - Taşkın, Gökmen - Çaksen, Hüseyin. “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”. Dicle Medical Journal 43/2 (June 1, 2016): 356-359. https://izlik.org/JA89CX28RH.
JAMA
1.Aktar F, Karaman K, Özgökçe Özmen B, Akıl M, Taşkın G, Çaksen H. Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal. 2016;43:356–359.
MLA
Aktar, Fesih, et al. “Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome”. Dicle Medical Journal, vol. 43, no. 2, June 2016, pp. 356-9, https://izlik.org/JA89CX28RH.
Vancouver
1.Fesih Aktar, Kamuran Karaman, Berfin Özgökçe Özmen, Muhammed Akıl, Gökmen Taşkın, Hüseyin Çaksen. Magnetic Resonance Spectroscopy in Sjögren-Larsson Syndrome. Dicle Medical Journal [Internet]. 2016 Jun. 1;43(2):356-9. Available from: https://izlik.org/JA89CX28RH